|
Dec 6
|
Natera Presents New Signatera™ MRD Data Across Breast Cancer Treatment Settings at SABCS 2023
|
|
Dec 2
|
Insider Sell Alert: Director Rowan Chapman Sells Shares of Natera Inc (NTRA)
|
|
Sep 7
|
Natera Announces Pricing of $250 Million Follow-On Offering
|
|
Sep 6
|
Natera Launches Proposed Follow-On Offering
|
|
Sep 5
|
Natera (NTRA) Reported Solid Quarterly Revenue Despite a Share Price Decline
|